ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 1,120 filers reported holding ASTRAZENECA PLC in Q4 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $845,568 | -18.7% | 10,842 | -29.3% | 0.66% | +9.4% |
| Q1 2024 | $1,039,692 | -46.7% | 15,346 | -47.0% | 0.60% | -55.3% |
| Q4 2023 | $1,950,187 | +82.3% | 28,956 | +83.3% | 1.35% | +69.2% |
| Q3 2023 | $1,069,841 | -0.5% | 15,798 | +5.2% | 0.80% | -7.1% |
| Q2 2023 | $1,074,767 | -2.4% | 15,017 | -5.4% | 0.86% | -16.9% |
| Q1 2023 | $1,101,606 | +39.3% | 15,871 | +10.1% | 1.04% | -2.7% |
| Q3 2022 | $791,000 | -41.1% | 14,415 | -29.0% | 1.06% | +4.1% |
| Q2 2022 | $1,342,000 | +51.6% | 20,311 | +63.9% | 1.02% | +44.1% |
| Q3 2014 | $885,000 | +68.3% | 12,395 | +75.0% | 0.71% | +18.5% |
| Q2 2014 | $526,000 | -32.4% | 7,081 | -40.9% | 0.60% | -11.1% |
| Q1 2014 | $778,000 | -11.4% | 11,991 | -18.9% | 0.67% | -7.8% |
| Q4 2013 | $878,000 | +79.2% | 14,790 | +56.7% | 0.73% | +28.0% |
| Q3 2013 | $490,000 | – | 9,441 | – | 0.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STARR INTERNATIONAL CO INC | 93,000 | $5,586,000 | 11.21% |
| Eagle Health Investments LP | 449,565 | $27,001,000 | 8.56% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,291,667 | $77,578,000 | 6.52% |
| Healthcare Value Capital, LLC | 50,000 | $3,003,000 | 5.93% |
| ARDSLEY ADVISORY PARTNERS LP | 500,000 | $30,030,000 | 4.58% |
| Asymmetry Capital Management, L.P. | 116,242 | $6,981,000 | 4.20% |
| Swaine & Leidel Wealth Services, LLC | 75,880 | $4,557,000 | 4.02% |
| Sofinnova Investments, Inc. | 1,128,272 | $67,764,000 | 4.01% |
| Eversept Partners, LP | 890,808 | $53,501,928 | 3.71% |
| Ruffer LLP | 1,971,796 | $117,064,000 | 3.70% |